Discontinuation report PMS-ALENDRONATE-FC
Report ID | 129698 |
Drug Identification Number | 02284006 |
Brand name | PMS-ALENDRONATE-FC |
Common or Proper name | ALENDRONATE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-12-07 |
Remaining supply date | 2020-12-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Demand transferred to 0 5760601684 3 pms-ALENDRONATE FC 70mg TABS BLI 1X4 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-12-08 | English | Compare |
v6 | 2020-12-07 | French | Compare |
v5 | 2020-12-07 | English | Compare |
v4 | 2020-12-07 | French | Compare |
v3 | 2020-12-07 | English | Compare |
v2 | 2020-12-07 | French | Compare |
v1 | 2020-12-07 | English | Compare |
Showing 1 to 7 of 7